Biotech Archives - Page 22 of 60 - Life Sciences Times

Firefly Health Becomes First National Primary Care Provider to Earn NCQA Virtual Care Accreditation

June 4, 2025

Amylyx Pharmaceuticals Earns FDA Fast Track Status for ALS Drug Candidate AMX0114

June 3, 2025

bluebird bio Acquired by Carlyle and SK Capital, Eyes Rapid Expansion Under New Leadership

June 2, 2025

THIS WEEK'S STORIES

European Commission Approves ADCETRIS Combination Therapy for Advanced Hodgkin Lymphoma

June 3, 2025

Latus Bio Expands Leadership Team with Key Executive Appointments

June 2, 2025

Bruker Unveils timsUltra AIP System with Breakthrough Sensitivity for Single-Cell Proteomics and Clinical Applications

June 2, 2025

ABOUT US

Life Science Times is New England’s premier life sciences publication, covering the Pharma, Biotech, MedTech and Public Health sectors nationwide with a special focus on New England. Updated daily, we cover the latest news in everything else that touches any rubric of the rapidly growing life sciences industry.

Biotech

Bruker Showcases Next-Generation Mass Spectrometry Innovations at ASMS 2025

FDA Grants Platform Technology Designation to Sarepta’s Viral Vector Used in SRP-9003 Gene Therapy

TriLink and Quantoom Partner to Expand Access to mRNA Vaccines and Therapeutics Globally

Washington-Area Emergency Responders Equip Hazardous Materials Teams with 908 Devices’ XplorIR Gas Analyzers

Enveric Biosciences Secures U.S. Patent for Novel Melatonin Receptor-Targeting Compounds

Most Read

Ontario Brain Injury Association Warns of Hidden Dangers in Surviving Opioid Overdoses

Canid Raises $10 Million to Modernize Pediatric Vaccine Management and Reduce Burden on Independent Practices

Cyberattacks Disrupt Patient Care in Nearly 1 in 5 Healthcare Organizations, Omega Systems Report Finds

Gore Launches 0.5 mL Silicone-Free Plunger for Ophthalmic Pre-Filled Syringes

EDITOR PICKS

Firefly Health Becomes First National Primary Care Provider to Earn NCQA Virtual Care Accreditation

Amylyx Pharmaceuticals Earns FDA Fast Track Status for ALS Drug Candidate AMX0114

bluebird bio Acquired by Carlyle and SK Capital, Eyes Rapid Expansion Under New Leadership

THIS WEEK'S STORIES

European Commission Approves ADCETRIS Combination Therapy for Advanced Hodgkin Lymphoma

Latus Bio Expands Leadership Team with Key Executive Appointments

Bruker Unveils timsUltra AIP System with Breakthrough Sensitivity for Single-Cell Proteomics and Clinical Applications

POPULAR CATEGORY

ABOUT US

FOLLOW US